The current earnings forecast score of Health In Tech Inc is 8.00, ranking 8 out of 117 in the Insurance industry. The average price target is 3.88, with a high of 4.50 and a low of 3.25.
Analyst Rating
Based on
2
analysts
Buy
Current Rating
4.033
Target Price
+299.34%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
20
Total
7
Median
8
Average
Company name
Ratings
Analysts
Health In Tech Inc
HIT
2
Prudential Financial Inc
PRU
20
MetLife Inc
MET
19
Corebridge Financial Inc
CRBG
16
Aflac Inc
AFL
16
Principal Financial Group Inc
PFG
15
1
2
3
4
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Health In Tech Inc's expected revenue for the next quarter?
Health In Tech Inc's expected revenue is 7.55M.
What is Health In Tech Inc's price target?
Analysts forecast that Health In Tech Inc's price target is USD 3.88, with the highest forecast at USD 4.50 and the lowest forecast at USD 3.25.
How have Health In Tech IncHIT's recent earnings per share performed?
The market expectation was USD -0.03, while Health In Tech IncHIT's earnings per share (EPS) for the previous quarter was USD -0.01. EPS for the next quarter is expected at USD -0.02.
What is the analyst rating for Health In Tech Inc?
Based on the ratings of Health In Tech Inc's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.